Stocks / CLB / P/E Ratio

Core Laboratories Inc. P/E Ratio 2021–2025

Core Laboratories Inc. reported 25.41 of price-to-earnings ratio for fiscal 2025. That was 2.7% lower than fiscal 2024. Compared with fiscal 2021, the change was -51.7%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.

Latest filed value
25.41
One-year change
-2.7%
Change since 2021
-51.7%
Latest period end
2025-12-31
Core Laboratories Inc. P/E Ratio history from 2021 to 2025FY 2021: 52.577545529320126FY 2022: 47.8596187773205FY 2023: 22.78397547734248FY 2024: 26.11461408210523FY 2025: 25.41105785067119
Annual filed history. Hover chart points for raw values; the accessible table below is the source of record.
Fiscal yearP/E RatioChange (YoY)
FY 202525.41-2.7%
FY 202426.11+14.6%
FY 202322.78-52.4%
FY 202247.86-9.0%
FY 202152.58—

Source: Core Laboratories Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open CLB 10-K filings at SEC EDGAR · Methodology · Download CSV.

How to read this history

Core Laboratories Inc. reported 25.41 of price-to-earnings ratio for fiscal 2025. That was 2.7% lower than fiscal 2024. Compared with fiscal 2021, the change was -51.7%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.

Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.

See the full picture for Core Laboratories Inc.

Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.

Open the interactive view — free

Core Laboratories Inc. — frequently asked questions

What is Core Laboratories Inc.'s price-to-earnings ratio?

Core Laboratories Inc. (CLB) reported price-to-earnings ratio of 25.41 for fiscal year 2025, per its SEC filings.

How has Core Laboratories Inc.'s price-to-earnings ratio changed over time?

Between fiscal 2021 and 2025, CLB's price-to-earnings ratio declined at roughly 16.6% per year (compound annual rate), from 52.58 to 25.41.

Where does this data come from?

Figures are computed from Core Laboratories Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.

More CLB financial history

CLB revenueCLB net incomeCLB gross profitCLB eps (earnings per share)CLB ebitdaCLB free cash flowCLB total debtCLB shares outstandingCLB dividend history

Full CLB fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →